These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1725915)
1. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group. Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915 [TBL] [Abstract][Full Text] [Related]
2. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group. Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877 [TBL] [Abstract][Full Text] [Related]
3. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension. Frishman WH; Goldberger J; Sherman D J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
5. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
7. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group. McClennen W; Wilson T Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004 [TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension. Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119 [TBL] [Abstract][Full Text] [Related]
10. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [TBL] [Abstract][Full Text] [Related]
11. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring. Cheung DG; Gasster JL; Weber MA Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118 [TBL] [Abstract][Full Text] [Related]
12. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies. Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394 [TBL] [Abstract][Full Text] [Related]
13. Once-daily treatment of essential hypertension with captopril. Schoenberger JA; Wilson DJ J Clin Hypertens; 1986 Dec; 2(4):379-87. PubMed ID: 3543231 [TBL] [Abstract][Full Text] [Related]
14. Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide. Jones DW; Sands CD Pharmacotherapy; 1991; 11(2):127-30. PubMed ID: 2052467 [TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group. Meyer BH; Pauly NC J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S77-80. PubMed ID: 7527107 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension]. Maarek-Charbit M; Stephan D; Welsch M; Galey-Arcangioli C; Imbs JL Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):509-13. PubMed ID: 1759789 [TBL] [Abstract][Full Text] [Related]
17. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial. Pathak L; Hiremath ; Kerkar PG; Manade VG J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effect of oral timolol maleate and hydrochlorothiazide once daily compared with hydrochlorothiazide once daily. Durley Y; Cubberley RB; Thomas S Am J Hosp Pharm; 1981 Aug; 38(8):1161-4. PubMed ID: 7270561 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension. Manning G; Joy A; Mathias CJ; McDonald CJ; Millar-Craig MW J Hum Hypertens; 1996 Jul; 10(7):443-8. PubMed ID: 8880557 [TBL] [Abstract][Full Text] [Related]
20. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]